Literature DB >> 27098426

Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis: response to comments by Li et al.

Hai-Long Ren1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27098426     DOI： 10.1007/s00586-016-4572-7

Source DB:  PubMed          Journal:  Eur Spine J        ISSN： 0940-6719            Impact factor:   3.134


× No keyword cloud information.
  9 in total

1.  Drug resistance patterns in 111 cases of drug-resistant tuberculosis spine.

Authors:  Kapil Mohan; Saurabh Rawall; Uday M Pawar; Meeta Sadani; Premik Nagad; Amita Nene; Abhay Nene
Journal:  Eur Spine J       Date:  2012-01-20       Impact factor: 3.134

2.  Management of drug-resistant spinal tuberculosis with a combination of surgery and individualised chemotherapy: a retrospective analysis of thirty-five patients.

Authors:  Litao Li; Zehua Zhang; Fei Luo; Jianzhong Xu; Peng Cheng; Zheng Wu; Qiang Zhou; Qingyi He; Fei Dai; Jian Wang; Jinsong Zhang
Journal:  Int Orthop       Date:  2011-11-09       Impact factor: 3.075

3.  Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system.

Authors:  Doris Hillemann; Sabine Rüsch-Gerdes; Catharina Boehme; Elvira Richter
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

4.  GeneXpert polymerase chain reaction for spinal tuberculosis: an accurate and rapid diagnostic test.

Authors:  M Held; M Laubscher; H J Zar; R N Dunn
Journal:  Bone Joint J       Date:  2014-10       Impact factor: 5.082

5.  Comments on Ren et al.: Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis?

Authors:  Fangfan Ye; HaiBo Li; Jia Huang
Journal:  Eur Spine J       Date:  2016-05-12       Impact factor: 3.134

6.  Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis?

Authors:  Hai-Long Ren; Jian-Ming Jiang; Ji-Xing Wang; Dong-Bin Qu; Jian-Ting Chen
Journal:  Eur Spine J       Date:  2016-03-07       Impact factor: 3.134

7.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

8.  Performance assessment of the CapitalBio mycobacterium identification array system for identification of mycobacteria.

Authors:  Jingbo Liu; Jun Yue; Zihe Yan; Min Han; Zhijun Han; Lingjie Jin; Yanlin Zhao
Journal:  J Clin Microbiol       Date:  2011-11-16       Impact factor: 5.948

9.  Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: a prospective validation study.

Authors:  Zehua Zhang; Litao Li; Fei Luo; Peng Cheng; Feng Wu; Zheng Wu; Tianyong Hou; Min Zhong; Jianzhong Xu
Journal:  BMC Infect Dis       Date:  2012-11-14       Impact factor: 3.090
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.